“…As might be expected, topical clindamycin was statistically superior to placebo in lesion count reductions and investigator/patient assessments in all 18 trials [16,39,47,[49][50][51]55,56,58,59,63,79,80,85,90,91] . The vehicle and the salt form (hydrochloride versus phosphate) did not affect efficacy [52,55,57] .…”